The Board of Partners of E. Merck KG has appointed two new members of the Executive Board of Merck KGaA: As of April 30, 2016, Udit Batra Head of the Life Science business sector, and Walter Galinat Head of the Performance Materials business sector, will become new members of the Executive Board while retaining their previous business responsibilities. Bernd Reckmann currently the Executive Board member responsible for Life Science and Performance Materials, will retire on conclusion of the Annual General Meeting on April 29, 2016. Udit Batra Prior to joining Merck, Batra worked for Novartis as Head of Global Public Health and Market Access for Vaccines and Diagnostics.

Bernd Reckmann started his career at Merck in 1986 in Diagnostics research, took over functions in marketing and sales, and was head of the Life Science Products division from 1998 to 2004.